KLRS
Kalaris Therapeutics Inc
$1.18M
Single buy
Discretionary Insider Activity
Date:
05/20/2026
Insiders:
AKKARAJU SRINIVAS, director
Prior trend:
20 weeks of no clear discretionary insider activity

Summary

A $1.18M single buy for Kalaris Therapeutics Inc (KLRS) on 05/20/2026 after 20 weeks of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Buy $1.18M 05/22/2026 AKKARAJU SRINIVAS + 3 Director, a 10%+ owner 0001231919-26-000532

Stake Changes

Action Insider Role(s) Total Change % Change
AKKARAJU SRINIVAS Director, a 10%+ owner unknown unknown

Transactions

Action Amount Date Insider Security Type SEC Code
Buy $1.18M 05/20/2026 AKKARAJU SRINIVAS Common Stock Discretionary Purchase
– 05/20/2026 AKKARAJU SRINIVAS Common Stock Non-discretionary Other
– 05/20/2026 AKKARAJU SRINIVAS Common Stock Non-discretionary Other
– 05/20/2026 AKKARAJU SRINIVAS Common Stock Non-discretionary Other

Stats

Prior max multiple:
91.7
Prior median multiple:
91.7

Metadata

Signal ID:
CCWRReKC0sQ28e1Q
Scanned on:
05/26/2026
Status:
Current